A Multi-center, Randomized, Controlled, Open-label Clinical Study to Evaluate the Efficacy and Safety of Mizoribine in Comparison With Cyclophosphamide in the Treatment of Lupus Nephritis
Phase of Trial: Phase III
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Mizoribine (Primary) ; Cyclophosphamide
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Asahi Kasei
- 15 Jan 2018 Planned End Date changed from 1 Mar 2018 to 1 Jan 2019.
- 15 Jan 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Jan 2019.
- 01 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Mar 2018.